Alharbi Abdullah, Al Turki Maram S, Aloudah Noura, Alsaad Khaled O
Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Case Rep Transplant. 2017;2017:4232474. doi: 10.1155/2017/4232474. Epub 2017 Oct 9.
The incidence of renal cell carcinoma (RCC) in renal allograft in transplant recipients is 0.22-0.25%. De novo clear cell, papillary, and chromophobe RCCs and RCCs with sarcomatoid differentiation originating in renal allograft have been reported. Routine surveillance for graft tumours is not routinely practiced and these tumours are commonly asymptomatic and incidentally discovered. We describe a case of incidental, eosinophilic chromophobe RCC in a 31-year-old, long-term renal transplant male recipient, who presented with acute gastroenteritis 11 years after transplantation. The graft was nonfunctional at the time of presentation. Abdominal ultrasound and computed tomography scan demonstrated 1.8 cm well-defined, round enhancing lesion, confined to the renal allograft and suspicious for malignancy. Pathological examination of graft nephrectomy specimen showed gross, histopathological, and immunohistochemical features of eosinophilic chromophobe RCC. Fifty-five months after surgery, the patient was alive and free of malignancy. To the best of our knowledge, only five chromophobe RCCs originating in a renal allograft were previously described in English literature. We suggest that chromophobe RCC should be considered in the differential diagnosis of renal allograft mass, including eosinophilic tumours, and emphasise the importance of periodic screening of renal allograft in all renal transplant recipients.
肾移植受者肾移植中肾细胞癌(RCC)的发生率为0.22 - 0.25%。已有报道在肾移植中出现的新发透明细胞癌、乳头状癌、嫌色细胞癌以及具有肉瘤样分化的RCC。目前尚未常规开展对移植肾肿瘤的监测,这些肿瘤通常无症状,多为偶然发现。我们描述了一例31岁长期肾移植男性受者的偶然发现的嗜酸性嫌色细胞RCC病例,该患者在移植11年后因急性肠胃炎就诊。就诊时移植肾已无功能。腹部超声和计算机断层扫描显示移植肾内有一个1.8厘米边界清晰、圆形强化的病灶,怀疑为恶性肿瘤。移植肾切除标本的病理检查显示具有嗜酸性嫌色细胞RCC的大体、组织病理学和免疫组化特征。术后55个月,患者存活且无恶性肿瘤复发。据我们所知,英文文献中此前仅报道过5例源自肾移植的嫌色细胞RCC。我们建议在肾移植肿块的鉴别诊断中,包括嗜酸性肿瘤,应考虑嫌色细胞RCC,并强调对所有肾移植受者定期筛查移植肾的重要性。